Literature DB >> 24508483

Can quantitative EEG measures predict clinical outcome in subjects at Clinical High Risk for psychosis? A prospective multicenter study.

Mirjam J van Tricht1, Stephan Ruhrmann2, Martijn Arns3, Ralf Müller2, Mitja Bodatsch2, Eva Velthorst4, Johannes H T M Koelman5, Lo J Bour5, Katharina Zurek2, Frauke Schultze-Lutter6, Joachim Klosterkötter2, Don H Linszen4, Lieuwe de Haan4, Anke Brockhaus-Dumke7, Dorien H Nieman4.   

Abstract

BACKGROUND: Prediction studies in subjects at Clinical High Risk (CHR) for psychosis are hampered by a high proportion of uncertain outcomes. We therefore investigated whether quantitative EEG (QEEG) parameters can contribute to an improved identification of CHR subjects with a later conversion to psychosis.
METHODS: This investigation was a project within the European Prediction of Psychosis Study (EPOS), a prospective multicenter, naturalistic field study with an 18-month follow-up period. QEEG spectral power and alpha peak frequencies (APF) were determined in 113 CHR subjects. The primary outcome measure was conversion to psychosis.
RESULTS: Cox regression yielded a model including frontal theta (HR=1.82; [95% CI 1.00-3.32]) and delta (HR=2.60; [95% CI 1.30-5.20]) power, and occipital-parietal APF (HR=.52; [95% CI .35-.80]) as predictors of conversion to psychosis. The resulting equation enabled the development of a prognostic index with three risk classes (hazard rate 0.057 to 0.81).
CONCLUSIONS: Power in theta and delta ranges and APF contribute to the short-term prediction of psychosis and enable a further stratification of risk in CHR samples. Combined with (other) clinical ratings, EEG parameters may therefore be a useful tool for individualized risk estimation and, consequently, targeted prevention.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinical High Risk; Psychosis prediction; QEEG

Mesh:

Substances:

Year:  2014        PMID: 24508483     DOI: 10.1016/j.schres.2014.01.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  16 in total

1.  Prediction and prevention of psychosis: current progress and future tasks.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Stefanie J Schmidt; Nathalie Kaiser; Joachim Klosterkötter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

Review 2.  [Prediction of psychoses].

Authors:  J Klosterkötter
Journal:  Nervenarzt       Date:  2014-10       Impact factor: 1.214

Review 3.  Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis.

Authors:  Holly K Hamilton; Alison K Boos; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2020-04-14       Impact factor: 13.382

Review 4.  Potential Roles of Redox Dysregulation in the Development of Schizophrenia.

Authors:  Diana O Perkins; Clark D Jeffries; Kim Q Do
Journal:  Biol Psychiatry       Date:  2020-04-02       Impact factor: 13.382

5.  Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.

Authors:  Ariel Schvarcz; Carrie E Bearden
Journal:  Curr Behav Neurosci Rep       Date:  2015-01-18

6.  Aberrant Current Source-Density and Lagged Phase Synchronization of Neural Oscillations as Markers for Emerging Psychosis.

Authors:  Avinash Ramyead; Michael Kometer; Erich Studerus; Susan Koranyi; Sarah Ittig; Ute Gschwandtner; Peter Fuhr; Anita Riecher-Rössler
Journal:  Schizophr Bull       Date:  2014-09-09       Impact factor: 9.306

Review 7.  The early identification of psychosis: can lessons be learnt from cardiac stress testing?

Authors:  Swapnil Gupta; Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2015-11-14       Impact factor: 4.530

8.  Thalamocortical dysrhythmia in patients with schizophrenia spectrum disorder and individuals at clinical high risk for psychosis.

Authors:  Minah Kim; Tak Hyung Lee; Hyungyou Park; Sun-Young Moon; Silvia Kyungjin Lho; Jun Soo Kwon
Journal:  Neuropsychopharmacology       Date:  2021-10-04       Impact factor: 7.853

Review 9.  Recent advances in understanding schizophrenia.

Authors:  Chiara S Haller; Jaya L Padmanabhan; Paulo Lizano; John Torous; Matcheri Keshavan
Journal:  F1000Prime Rep       Date:  2014-07-08

Review 10.  Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological Targets.

Authors:  Frauke Schultze-Lutter; Martin Debbané; Anastasia Theodoridou; Stephen J Wood; Andrea Raballo; Chantal Michel; Stefanie J Schmidt; Jochen Kindler; Stephan Ruhrmann; Peter J Uhlhaas
Journal:  Front Psychiatry       Date:  2016-01-28       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.